Standard Chemical & Pharmaceutical Co (TPE:1720) Cash-to-Debt : 1.44 (As of Mar. 2024)

View and export this data going back to 1995. Start your Free Trial

What is Standard Chemical & Pharmaceutical Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Standard Chemical & Pharmaceutical Co's cash to debt ratio for the quarter that ended in Mar. 2024 was 1.44.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Standard Chemical & Pharmaceutical Co could pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Standard Chemical & Pharmaceutical Co's Cash-to-Debt or its related term are showing as below:

TPE:1720' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.02 Med: 1.28 Max: 1.84
Current: 1.44

During the past 13 years, Standard Chemical & Pharmaceutical Co's highest Cash to Debt Ratio was 1.84. The lowest was 1.02. And the median was 1.28.

TPE:1720's Cash-to-Debt is ranked better than
56.42% of 989 companies
in the Drug Manufacturers industry
Industry Median: 0.96 vs TPE:1720: 1.44

Standard Chemical & Pharmaceutical Co Cash-to-Debt Historical Data

The historical data trend for Standard Chemical & Pharmaceutical Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Standard Chemical & Pharmaceutical Co Cash-to-Debt Chart

Standard Chemical & Pharmaceutical Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash-to-Debt

Get a 7-Day Free Trial

1.19

1.32

1.46

1.52

1.16

Standard Chemical & Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															1.16	1.21	1.38	1.14	1.44

Competitive Comparison of Standard Chemical & Pharmaceutical Co's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Standard Chemical & Pharmaceutical Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Standard Chemical & Pharmaceutical Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Standard Chemical & Pharmaceutical Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Standard Chemical & Pharmaceutical Co's Cash-to-Debt falls into.

Standard Chemical & Pharmaceutical Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Standard Chemical & Pharmaceutical Co's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2599.039	/	(1829.066	+	418.696)
	=	1.16

Standard Chemical & Pharmaceutical Co's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	2138.752	/	(1057.918	+	429.43)
	=	1.44

Standard Chemical & Pharmaceutical Co (TPE:1720) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Standard Chemical & Pharmaceutical Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Standard Chemical & Pharmaceutical Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Standard Chemical & Pharmaceutical Co (TPE:1720) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Standard Chemical & Pharmaceutical Co Ltd (TPE:1720) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 154, Kaiyuan Road, Xinying District, Tainan, TWN, 73055

Website

https://www.standard.com.tw

Standard Chemical & Pharmaceutical Co Ltd is a pharmaceutical company. Along with its subsidiaries, the firm is engaged in the pharmaceutical development, manufacturing, and sales of Active Pharmaceuticals Ingredients (API), health supplements, medical equipment, neoangelac plus milk powder, and adult supplements. It offers pharmaceutical products in healthcare segments including the circulatory system, digestive system, metabolism, anti-microbial, membrane drugs, and respiratory system. The company generates a majority of its revenue from Taiwan.

Standard Chemical & Pharmaceutical Co (TPE:1720) Headlines

No Headlines